Use of biofluorescence imaging to compare the distribution of certolizumab pegol, adalimumab, and infliximab in the inflamed paws of mice with collagen-induced arthritis (Q84147505)
Jump to navigation
Jump to search
scientific article published on 28 June 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Use of biofluorescence imaging to compare the distribution of certolizumab pegol, adalimumab, and infliximab in the inflamed paws of mice with collagen-induced arthritis |
scientific article published on 28 June 2009 |
Statements
Use of biofluorescence imaging to compare the distribution of certolizumab pegol, adalimumab, and infliximab in the inflamed paws of mice with collagen-induced arthritis (English)
Roger Palframan
Michael Airey
Adrian Moore
Alex Vugler